Sonnet BioTherapeutics

1 follower

‌

Sonnet’s proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms.

Industries

Headquarters

Stage

Employees

Links

Org chart

Pankaj Mohan

Founder, CEO & Chairman

Pankaj Mohan

Collapse

John K. Cini

Chief Scientific Officer & Co Founder

Jay Cross

CFO

Susan Dexter

Chief Technical Officer

Richard Kenney

Chief Medical Officer

Stephen J. McAndrew

Vice President, Business Development

Kal Ghosh

Executive Administrative Assistant

Teams

Directors

5 members

Leadership Team

5 members

Advisory Team

4 members

Similar companies

Calico

6 followers

Inceptive

5 followers

Forge Biologics

2 followers

BioTeam

2 followers

Day One Biopharmaceuticals

1 follower

Discover companies